Transcriptomic Analysis of s63 as a Prognostic Score of FDY-5301 Effectiveness in Trauma Patients A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Intravenous FDY-5301 for the Prevention and Treatment of ICU Acquired Weakness in Major Trau